Trump Taps Ex-Glaxo Official and General to Lead Vaccine Race
- Moncef Slaoui oversaw Glaxo development of Rotarix, Cervarix
- Slaoui to lead Operation Warp Speed with four-star general
Photographer: George Frey/Bloomberg
This article is for subscribers only.
President Donald Trump plans to name Moncef Slaoui, the former head of GlaxoSmithKline Plc’s vaccines division, and Gustave Perna, a four-star U.S. general, to lead a Manhattan Project-style effort to develop a vaccine for the novel coronavirus, two people familiar with the matter said.
Slaoui, 60, and Perna will oversee the initiative known as Operation Warp Speed, according to the people, who spoke on condition of anonymity ahead of an announcement expected later Wednesday. Slaoui will work on a volunteer basis.